Image

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Description

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia. Participants will all be taking an antipsychotic medication and half will have a diagnosis of Tardive Dyskinesia and half will not. Participant responses to interview questions and elements of the Abnormal Involuntary Movement Scale will be collected on video. The videos will be rated by trained observers. Machine learning methods will be used to develop an algorithm to detect abnormal movements in individuals with a known Tardive Dyskinesia diagnosis. The trained rater results will be compared to the algorithm to determine the accuracy of the algorithm.

Eligibility

Inclusion Criteria:

For the non-TD group:

  1. Prescribed and taking an antipsychotic medication for 90-days or longer.
  2. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
  3. Signed an informed consent.
  4. Speaks English fluently.

Exclusion Criteria:

  1. Suffered a moderate or severe head injury in the last year;
  2. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
  3. Severe visual impairment that is cannot be corrected by glasses or contacts.

Study details

Tardive Dyskinesia

NCT06011408

iRxReminder

19 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.